Reference health
Glucocorticoids and Rheumatoid Arthritis
35/35 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
6 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 35 checked references that resolve
resolves10.1111/j.1749-6632.2002.tb04199.x
Fifty Years of Experience with Cortisone Therapy in the Study and Treatment of Rheumatoid Arthritis
resolves10.1002/art.20583
Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of action
resolves10.1136/bmj.316.7134.811
Meta-analysis of short term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis
resolves10.1093/rheumatology/kes085
Symptom control with low-dose glucocorticoid therapy for rheumatoid arthritis
resolves10.1016/S0140-6736(08)60132-4
Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial
resolves10.1136/annrheumdis-2011-201067
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)
resolves10.1016/j.jbspin.2009.12.010
Use of glucocorticoids in rheumatoid arthritis – Pratical modalities of glucocorticoid therapy: Recommendations for clinical practice based on data from the literature and expert opinion
resolves10.1016/S0140-6736(97)01300-7
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
resolves10.1002/art.21298
Low‐dose prednisolone in addition to the initial disease‐modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two‐year randomized trial
resolves10.1136/ard.2004.030908
A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs
resolves10.1136/ard.2009.114579
Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
resolves10.1002/acr.20295
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
resolves10.1136/ard.2009.124958
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice
resolves10.7326/0003-4819-114-9-735
Corticosteroid Use and Peptic Ulcer Disease: Role of Nonsteroidal Anti-inflammatory Drugs
resolves10.1136/ard.2005.038638
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
resolves10.1210/en.2003-0990
Glucocorticoids Act Directly on Osteoblasts and Osteocytes to Induce Their Apoptosis and Reduce Bone Formation and Strength
resolves10.1159/000362726
Safety of Glucocorticoids in Rheumatoid Arthritis: Evidence from Recent Clinical Trials
resolves10.1136/ard.2011.151464
Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids
resolves10.1136/ard.2007.072157
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
resolves10.1002/art.22368
Circadian rhythms in rheumatoid arthritis: Implications for pathophysiology and therapeutic management
resolves10.1186/ar4686
The value of glucocorticoid co-therapy in different rheumatic diseases - positive and adverse effects
resolves10.1186/ar2383
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
resolves10.1002/art.10359
Atherosclerosis in rheumatoid arthritis: Morphologic evidence obtained by carotid ultrasound
resolves10.1186/ar2591
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study
resolves10.1186/ar3453
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses
resolves10.1016/j.autrev.2010.12.003
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases
resolves10.1097/00004872-198907000-00005
The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume
resolves10.1016/j.mce.2007.05.014
Selective glucocorticoid receptor agonists (SEGRAs): Novel ligands with an improved therapeutic index
The 6 references without a DOI — listed, not checked
no DOI — not checkedEffects of glucocorticoids on radiological progression in rheumatoid arthritis
no DOI — not checkedModerate-term, low-dose corticosteroids for rheumatoid arthritis
no DOI — not checkedGlucocorticoid in rheumatic diseases
no DOI — not checkedVaccinations in patients with autoimmune inflammatory rheumatic diseases–EULAR recommendations for pediatric and adult patients
no DOI — not checked10.1016/j.rdc.2015.08.006_bib37
no DOI — not checkedCurrent issues of basic and clinical glucocorticoid research
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.rdc.2015.08.006"><img src="https://citestamp.com/citestamped/10.1016/j.rdc.2015.08.006/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.rdc.2015.08.006)